Stocks Dip On Weak GDP Data; Monster Quarter For Amazon

This article was originally published on this site

The stock market edged lower Friday as Wall Street weighed another strong earnings report from (AMZN) but worried about a weaker-than-expected preliminary reading on Q2 gross domestic product.

Leaderboard name Amazon added just over 1%. Late Wednesday, the company smashed earnings estimates and reported its second straight quarter of accelerating sales growth.

The Dow Jones industrial average gave back 0.4%, while the S&P 500 and Nasdaq composite eased 0.2% apiece. Volume on the NYSE and Nasdaq was tracking lower than Thursday’s levels in the stock market today.

In the other global markets, Tokyo’s Nikkei 225 bumped up 0.5% after the Bank of Japan voted for a mild increase in its monetary stimulus measures.

Exxon Mobil (XOM) and Chevron (CVX) were early laggards in the Dow as West Texas Intermediate crude oil dipped below $41 a barrel. Merck (MRK) and Microsoft (MSFT) outperformed with gains of around 0.5% each.

In economic news, a preliminary read on Q2 gross domestic product showed growth of 1.2%, well below the consensus estimate of 2.6%. Gold was mostly unchanged ahead of the GDP data but picked up steam afterwards, rising 0.7% to $1,341.50 an ounce. The 10-year Treasury yield picked up 1 basis points to 1.51%.

Medical-device maker Abiomed (ABMD) added 2%. Shares have been in a nice accumulation phase as the stock sits just 1% off an all-time high.

IBD’S TAKE: Abiomed is one of several leaders in the strong-performing Medical-Products group. See who the other Leaders are with IBD Stock Checkup.

IBD 50 name B&G Foods (BGS) soared 12% after reporting strong earnings late Thursday. Quarterly profit jumped 68% from a year earlier. Sales jumped 58% to $306.4 million. Results were helped by its acquisition last year of the Green Giant and Le Sueur brands from General Mills (GIS).